Fecal Carriage of Extended-Spectrum β-Lactamase and CarbapenemaseProducing Enterobacterales among Oncology Patients at St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia

dc.contributor.advisorMelese Hailu
dc.contributor.advisorDessie Abera
dc.contributor.advisorAbdu Adem
dc.contributor.authorTsedaleWoldu
dc.date.accessioned2026-11-13T13:15:56Z
dc.date.available2026-11-13T13:15:56Z
dc.date.issued2026-06-01
dc.description.abstractIntroduction: Antimicrobial Resistance (AMR) Is A Major Public Health Problem Worldwide, With Extended-Spectrum Β-Lactamase (ESBL) And Carbapenems-Producing Enterobacter ales Contributing Significantly to Multidrug Resistance. These Organisms Colonize the Gastrointestinal Tract and Act as A Reservoir for Serious Infections. Oncology Patients Are Especially at Risk Because Of Immunosuppression and Repeated Exposure to Antibiotics. Objective: To Determine the Fecal Carriage Rate of Extended-Spectrum Β-Lactamase and Carbapenems-Producing Enterobacter ales Among Oncology Patients at St. Paul’s Millennium Medical College Hospital, Addis Ababa, Ethiopia Method: A Cross-Sectional Study Was Conducted at The Oncologic Unit of St. Paul’s Hospital Millennium Medical College from January to March 2025. Oncology Patients Were Enrolled Using A Consecutive Sampling Technique. Stool Samples Were Screened Using Chromogenic Media For ESBL- And Carbapenems-Producing Enterobacter ales. Isolates Were Identified Using Conventional Biochemical Tests. Kirby–Bauer Disk Diffusion Method Was Used to Determine Antimicrobial Susceptibility of Isolates. Production Of ESBL Enzyme Was Confirmed Busing the Combination Disk Method, While Production of Carbapenems Was Confirmed Using the Modified Carbapenem Inactivation Method (Mcim). Data Were Entered Using Kobo Toolbox and Analyzed Using SPSS Version 27. Univariate And Bivariate Analyses Were Performed, And Associations Were Assessed Using Theap-Value of Less Than 0.05 Was Regarded as Statistically Significant. Result: Among 226 Cancer Patients, The Intestinal Carriage Rate Of ESBL-Producing Enterobacter ales (ESBL-PE) Was 67.3% (152/226), And Carbapenems-Producing Enterobacter ales (CPE)Was 17.7% (40/226), Predominantly E. coli. ESBL-Producing Isolates Showed the Highest Resistance to Ciprofloxacin (52.5%) And Cefepime (43%), While Amikacin Had the Lowest Resistance (4.4%). CPE Isolates Exhibited Very High Resistance to Ceftazidime and Cefotaxime (97.7%), Cefepime (95.5%), And Ciprofloxacin (93.3%), With Comparatively Lower Resistance to Amikacin (55.5%). 14.6% ESBL-PE And 57.8% CPE Isolates Were Multidrug Resistant. Repeated Antibiotic Treatment and Indwelling Devices Were Associated With ESBL-PE Carriage, While Age, Male Sex, And Comorbidities Were Associated with CPE Carriage (P<0.05). Conclusion: Most Isolates Recovered from Fecal Specimens of Oncology Patients Were Resistant To Multiple Antibiotic Classes, And Some Showed Reduced Susceptibility to Carbapenems. These Findings Underscore the Need for Routine Screening, Strict Infection Prevention, And Judicious Antibiotic Use to Protect Vulnerable Patients and Curb the Spread of Antimicrobial resistance.
dc.identifier.urihttps://etd.aau.edu.et/handle/123456789/9629
dc.language.isoen
dc.publisherAddis Ababa University
dc.subjectEnterobacterales
dc.subjectFecal carriage
dc.subjectESBL
dc.subjectCPE
dc.subjectOncology
dc.titleFecal Carriage of Extended-Spectrum β-Lactamase and CarbapenemaseProducing Enterobacterales among Oncology Patients at St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia
dc.typeThesis

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Tsedale Final thesis AUEST 20 (Repaired).pdf
Size:
1.13 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: